Table 1 Baseline characteristics of patients among the three groups

Age (years) ± mean (SD)

59.08 ± 10.65^*

68.46 ± 12.32

64.30 ± 15.64

<0.001

Sex (male), n (%)

83 (79.8%)

33 (66.0%)

8 (80.0%)

0.165

Hypertension

66 (63.5%)

39 (78.0%)

7 (70.0%)

0.191

Diabetes

28 (26.9%)

20 (40.0%)

3 (30.0%)

0.259

Coronary Heart Disease

10 (9.6%)

6 (12.0%)

2 (20.0%)

0.582

Atrial Fibrillation

16 (15.4%)^*

16 (32.0%)

1 (10.0%)

0.039

Hyperlipidemia

35 (33.7%)

8 (16.0%)

2 (20.0%)

0.061

Previous Stroke, n (%)

23 (22.1%)

15 (30.0%)

5 (50.0%)

0.123

Smoking status, n (%)

64 (61.5%)

26 (52.0%)

6 (60.0%)

0.529

Drinking status, n (%)

50 (44.2%)

15 (30.0%)

4 (40.0%)

0.266

NIHSS on Admission, median (IQR)

6 (3,10)^*#

16 (8,23)

21.5 (14.75-26)

<0.001

mRS on Admission, median (IQR)

4 (3,4)^*#

5 (4,5)

5 (4.75,5)

<0.001

GCS on Admission, median (IQR)

15 (13,15)^*#

11.5 (7,14)

8 (5.5,10.75)

<0.001

Dysphagia, n (%)

22 (21.2%)^*#

32 (64.0%)^&

10 (100%)

<0.001

Enteral Nutrition, n (%)

29 (27.9%)^*#

47 (94.0%)

10 (100%)

<0.001

MV before pneumonia, n (%)

0 (0.0%)

10 (100%)

MV after pneumonia, n (%)

42 (84.0%)

10 (100%)

Oral hygiene care, n (%)

104 (100%)

50 (100%)

10 (100%)

1

Revascularization therapies, n (%)

0.106

 Intravenous Thrombolysis

16 (15.4%)

1 (2.0%)

0 (0.0%)

 Endovascular Thrombectom

53 (51.0%)

33 (66.0%)

7 (70.0%)

 Bridging Therapy

11 (10.6%)

7 (14.0%)

2 (20.0%)

 Drug Treatment

24 (23.1%)

9 (18.0%)

1 (10.0%)

Stroke subtype, n (%)

0.569

 Large artery disease

65 (62.5%)

34 (68.0%)

8 (80.0%)

 Cardioembolism

21 (20.2%)

11 (22.0%)

1 (10.0%)

 Small vessel occlusion

10 (9.6%)

1 (2.0%)

0 (0.0%)

 Others

8 (7.7%)

4 (8.0%)

1 (10.0%)

ICU length of stay, median (IQR)

2 (1,3)^*#

7.5 (3,15)

11 (5.75,17.5)

<0.001

30-day mRS, median (IQR)

2 (1,3)^*#

5 (4,5)

5 (4.75,6)

<0.001

90-day mRS, median (IQR)

1 (0,2)^*#

5 (3,6)

5 (4.75,6)

<0.001

30-day motality, n (%)

4 (3.8%)^*#

7 (14.0%)

3 (30.0%)

0.005